AccessClosure Launches MynxGrip Vascular Closure Device

February 27, 2012—AccessClosure, Inc. (Mountain View, CA) announced the FDA approval and US launch of the MynxGrip vascular closure device (VCD). 

According to AccessClosure, the MynxGrip VCD offers an active, extravascular, and patient-friendly vascular closure solution. The device incorporates the company's Grip Technology sealant to the distal end of the original Mynx sealant. The sealant actively grips and seals the arteriotomy while expanding and filling the tissue tract, providing a durable hemostasis. 

The MynxGrip sealant consists of the same PEG polymer used in the original Mynx sealant. Grip Technology is a new configuration of PEG that adheres to the contours of the vessel wall, providing active closure of the arteriotomy. The MynxGrip sealant fully resorbs within 30 days. Grip Technology has been used in international markets and is now commercially available in the United States, stated the company.

"There has been a long-standing perception that closure devices which 'actively' close the arteriotomy with sutures or clips provide greater security and have better results," commented Stevan Himmelstein, MD. "Unfortunately, the tradeoff for these closure devices has been leaving foreign material permanently behind in the artery. MynxGrip is the first closure device which provides the benefits of an active, secure close while also being completely extravascular and bioabsorbable."